Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient characteristics

From: Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis

Patient Age (years)/sex Disease duration (years) Treatment
1 54/M 5 Azathioprine, methylprednisolone
2 38/F 6 Hydroxychloroquine, salazopyrine
3 64/F 7 NSAID
4 43/F 5 NSAID
5 46/M 1 Salazopyrine
6 46/M <1 Salazopyrine
7 52/M 11 NSAID
8 53/F 11 NSAID
9 49/M 10 NSAID
10 52/F 4 NSAID
11 69/F 36 Salazopyrine
12 65/F <1 Untreated
13 35/M <1 Untreated
14a 57/F 4 Methotrexate
15a 46/M 2 Anti-TNF, salazopyrine
16a 41/M 10 Salazopyrine
17a 41/M 13 Methotrexate
18a 60/M 2 Leflunomide
19a 43/F 5 Methotrexate
20b 63/M 17 Salazopyrine
21a,b 65/F 4 Salazopyrine, hydroxychloroquine
22b 62/F 12 Leflunomide
23b 54/F 17 Methylprednisolone
  1. aSynovial fluid sample. bSynovial tissue sample. F, female; M, male; NSAID, nonsteroidal anti-inflammatory drug; TNF, tumour necrosis factor.